Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
News
News
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Prof. Nir Peled, MD, PhD, FCCP
lungcanc
Lee M. Krug, MD
Frances Shepherd, MD
Alice Shaw, MD
Abbas El-Sayed Abbas, MD
Dr. Benjamin Levy, MD
lungcanc
Gideon M. Blumenthal, MD
lungcanc
Dr. James D. Cox
lungcanc
IASLC Journals Share Exciting Milestones on Metrics Journeys
lungcanc
Roman Perez-Soler, MD
lungcanc
Vinicius Ernani, MD
lungcanc
Breaking News Briefs
lungcanc
Scott Antonia, MD, PhD
lungcanc
Glen Weiss, MD, MBA
lungcanc
Karen Kelly, MD
lungcanc
1
2
3
...
13
Page 1 of 13
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
